TNF-α inhibitors in the treatment of hidradenitis suppurativa
Hidradenitis suppurativa (HS) is a complex disease with a dramatic impact on the quality of life of patients that it afflicts. Despite this, there are few treatment options offering long-term relief. The exact pathophysiology of HS is unclear, although the current theory involves follicular obstruct...
Saved in:
Main Authors: | Kevin T. Savage (Author), Kelsey S. Flood (Author), Martina L. Porter (Author), Alexa B. Kimball (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients
by: Kevin T. Savage, BA, et al.
Published: (2020) -
Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
by: Kevin T. Savage, BA, et al.
Published: (2020) -
Response to: Remission of hidradenitis suppurativa after bariatric surgery
by: Nicole Mona Golbari, BA, et al.
Published: (2018) -
Prednisone and amoxicillin/clavulanic acid for the treatment of hidradenitis suppurativa flares: a prospective observational study
by: Ruby S. Gibson, MD, et al.
Published: (2024) -
Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
by: Peyton C. Morss-Walton, BA, et al.
Published: (2022)